Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer

Authors: Paz-Ares, Luis G., Pérol, Maurice, Ciuleanu, Tudor-Eliade, Kowalyszyn, Ruben Dario, Reck, Martin, Lewanski, Conrad R., Syrigos, Konstantinos, Arrieta, Oscar, Prabhash, Kumar, Park, Keunchil, Pikiel, Joanna, Göksel, Tuncay, Lee, Pablo, Zimmermann, Anna, Carter, Gebra Cuyun, Alexandris, Ekaterine, Garon, Edward B.

Source: In Lung Cancer October 2017 112:126-133

Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy

Authors: Pérol, Maurice, Ciuleanu, Tudor-Eliade, Arrieta, Oscar, Prabhash, Kumar, Syrigos, Konstantinos N., Goksel, Tuncay, Park, Keunchil, Kowalyszyn, Ruben Dario, Pikiel, Joanna, Lewanski, Conrad R., Thomas, Michael, Dakhil, Shaker, Kim, Joo-Hang, Karaseva, Nina, Yurasov, Sergey, Zimmermann, Annamaria, Lee, Pablo, Carter, Gebra Cuyun, Reck, Martin, Cappuzzo, Federico, Garon, Edward B.

Source: In Lung Cancer March 2016 93:95-103

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Authors: Garon, Edward B, Ciuleanu, Tudor-Eliade, Arrieta, Oscar, Prabhash, Kumar, Syrigos, Konstantinos N, Goksel, Tuncay, Park, Keunchil, Gorbunova, Vera, Kowalyszyn, Ruben Dario, Pikiel, Joanna, Czyzewicz, Grzegorz, Orlov, Sergey V, Lewanski, Conrad R, Thomas, Michael, Bidoli, Paolo, Dakhil, Shaker, Gans, Steven, Kim, Joo-Hang, Grigorescu, Alexandru, Karaseva, Nina, Reck, Martin, Cappuzzo, Federico, Alexandris, Ekaterine, Sashegyi, Andreas, Yurasov, Sergey, Pérol, Maurice

Source: In The Lancet 23-29 August 2014 384(9944):665-673

Radiotherapy and cellular signalling

Authors: Lewanski, Conrad R, Gullick, William J

Source: In Lancet Oncology 2001 2(6):366-370

This result is not displayed to guests.
Login for full access.

Pegylated liposomal adriamycin: a review of current and future applications

Authors: Lewanski, Conrad R ^*, Stewart, Simon

Source: In Pharmaceutical Science & Technology Today 1999 2(12):473-477

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases.

Authors: Siow Ming Lee, Lewanski, Conrad R., Counsell, Nicholas, Ottensmeier, Christian, Bates, Andrew, Patel, Nirali, Wadsworth, Christina, Yenting Ngai, Hackshaw, Allan, Faivre-Finn, Corinne

Source: JNCI: Journal of the National Cancer Institute; Jul2014, Vol. 106 Issue 7, p1-7, 7p, 1 Diagram, 2 Charts, 1 Graph

Subject Terms: ERLOTINIB, BRAIN metastasis, RADIOTHERAPY, LUNG cancer treatment, EPIDERMAL growth factor receptors, THERAPEUTICS

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.